| 04:13p | SECTOR UPDATE : Health Care Stocks End Near Unchanged | MT |
| 02:14p | SECTOR UPDATE : Health Care Stocks Falling This Afternoon | MT |
| 01:29p | SECTOR UPDATE : Health Care | MT |
| 06:03a | French health body backs new COVID vaccine booster campaign for this autumn | RE |
| 05/24 | Lonza Ties Up With Israel Biotech Fund On Biologics, Small Molecule Development, Manufa.. | MT |
| 05/24 | Moderna's CEO Stephane Bancel to Exercise Shares, Intends to Donate Proceeds to Charity | MT |
| 05/24 | Rubius Therapeutics Names Noubar Afeyan Chairman; Shares Rise Pre-Bell | MT |
| 05/24 | TRANSCRIPT : Moderna, Inc. Presents at UBS Global Healthcare Conference, May-24-2022 09:15.. | CI |
| 05/24 | Moderna testing potential monkeypox vaccines | RE |
| 05/24 | Moderna CEO to Exercise 2013 Option, Donate Funds to Charity | DJ |
| 05/24 | ANALYST RECOMMENDATIONS : Chubb, Glencore, Metlife, Moonpig, Salesforce... | |
| 05/24 | Guggenheim Starts IQVIA Holdings at Buy With $244 Price Target | MT |
| 05/23 | Switzerland's Lonza to Scale Up Inhalation Capabilities at US Site | MT |
| 05/23 | Seagen Sees Positive Topline Data From Study of Tukysa With Trastuzumab in HER2-Positiv.. | MT |
| 05/23 | What you need to know about the coronavirus right now | RE |
| 05/23 | Seagen Inc. Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUK.. | CI |
| 05/23 | INSIDER SELL : Moderna | MT |
| 05/19 | EU health regulator backs using AstraZeneca COVID shot as booster | RE |
| 05/18 | Moderna Seeks Swissmedic Nod For COVID-19 Shot In Children Aged Six Months To Five year.. | MT |
| 05/18 | As COVID cases rise, U.S. health officials mull widening additional booster eligibility | RE |
| 05/18 | Lonza Opens New Facility for Kodiak Sciences' Retinal Diseases Drug | MT |
| 05/18 | Moderna, International AIDS Vaccine Initiative to Start Volunteer Screening for Phase 1.. | MT |
| 05/18 | Piper Sandler Adjusts Moderna's Price Target to $214 From $348, Reiterates Overweight R.. | MT |
| 05/18 | From storage to transport, hurdles to getting COVID vaccine to N.Koreans | RE |
| 05/17 | TRANSCRIPT : Moderna, Inc. - Special Call | CI |
| 05/17 | FDA Expands Authorization of Pfizer Covid Booster to Kids 5 to 11 | DJ |
| 05/16 | US Stocks Begin Week Mostly Lower Amid Empire State Manufacturing Weakness | MT |
| 05/16 | US Stocks Begin Week Mostly Lower as First Manufacturing Data for May Turns Negative | MT |
| 05/16 | Top Midday Gainers | MT |
| 05/16 | INSIDER SELL : Seagen | MT |
| 05/16 | Seagen's President, CEO Clay Siegall Resigns Amid Investigation | MT |
| 05/16 | Seagen Announces Resignation of Clay Siegall as CEO | CI |
| 05/13 | SECTOR UPDATE : Health Care Stocks Gain Premarket Friday | MT |
| 05/13 | Swiss Medical Regulator Approves Moderna's Covid-19 Vaccine for 6-11-Year-Olds | MT |
| 05/13 | Swissmedic OKs Moderna's COVID-19 Jab For Children Aged Six To 11 Years | MT |
| 05/13 | N.Korea gets offers of aid to fight COVID as it lacks vaccines | RE |
| 05/13 | Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds | RE |
| 05/11 | Moderna completes FDA submission for use of COVID shot in adolescents, kids | RE |
| 05/11 | Moderna, Inc. Fires Jorge Gomez as CFO | CI |
| 05/11 | Pfizer's $11.6 billion Biohaven buy could spark more biotech deals | RE |
| 05/11 | Moderna Ousts New Finance Chief Amid Probe at Dentsply | DJ |
| 05/11 | Moderna Says Recently Named CFO Jorge Gomez Departs; David Meline Continues as CFO | MT |
| 05/11 | Moderna CFO, Jorge Gomez, Resigns Effective Immediately | MT |
| 05/11 | Moderna CFO exits a day after taking charge as former employer launches probe | RE |
| 05/11 | Moderna's new CFO Jorge Gomez steps down | RE |
| 05/10 | What you need to know about the coronavirus right now | RE |
| 05/10 | Novavax shares slide 20% on COVID vaccine demand uncertainty | RE |
| 05/09 | Lonza, ALSA Ventures Partner To Support Development Of Small Molecule Drug Candidates | MT |
| 05/09 | Novavax 2022 COVID vaccine deliveries off to slow start, shares drop | RE |
| 05/09 | Novavax posts drop in COVID research funding, slow start to 2022 vaccine delivery | RE |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
